COŞKUN, B. N. Et Al. 2019. The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment. Współczesna Onkologia , vol.23, no.4 , 208-213.

COŞKUN, B. N., Dizdar, O. s., Korkmaz, S., ULUKAYA, E., & EVRENSEL, T., (2019). The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment. Współczesna Onkologia , vol.23, no.4, 208-213.

COŞKUN, BELKIS Et Al. "The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment," Współczesna Onkologia , vol.23, no.4, 208-213, 2019

COŞKUN, BELKIS N. Et Al. "The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment." Współczesna Onkologia , vol.23, no.4, pp.208-213, 2019

COŞKUN, B. N. Et Al. (2019) . "The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment." Współczesna Onkologia , vol.23, no.4, pp.208-213.

@article{article, author={BELKIS NİHAN COŞKUN Et Al. }, title={The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment}, journal={Współczesna Onkologia}, year=2019, pages={208-213} }